Chris joined Camber in February 2024 and focuses on work that brings together global health actors to act in partnership to promote equitable health outcomes and access to life-saving medicines.

Prior to joining Camber, Chris spent five and a half years at Boston Consulting Group in the London and San Francisco offices, focused on global health and biopharma research and development, strategy design, and implementation. Chris has a background as a research scientist as a Postdoctoral Research Associate in molecular neuroscience, holding a PhD in molecular cell biology from University College London. He also holds a BA in Physiological Sciences from the University of Oxford. Outside of work, Chris enjoys flower arranging, swimming, and having a beer or three at the pub with friends.